MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1234.39

Change

+3.65 (+0.30)%

Market Cap

USD 10.87B

Volume

0.09M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+0.61 (+0.27%)

USD 165.08B
A Agilent Technologies Inc

+0.09 (+0.07%)

USD 40.09B
IQV IQVIA Holdings Inc

+1.84 (+0.93%)

USD 36.13B
LH Laboratory Corporation of Amer..

-0.77 (-0.34%)

USD 19.12B
DGX Quest Diagnostics Incorporated

-0.16 (-0.10%)

USD 17.09B
QGEN Qiagen NV

+0.15 (+0.34%)

USD 10.26B
CRL Charles River Laboratories

-0.38 (-0.20%)

USD 9.50B
VNRX Volitionrx Ltd

-0.07 (-9.75%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-2.85%)

USD 0.04B
TMO Thermo Fisher Scientific Inc

+1.24 (+0.24%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.03 (+0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.05 (0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

+0.16 (+0%)

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-1.39 (0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+0.88 (+0%)

USD 6.91B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.77% 69% C- 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.77% 69% C- 31% F
Trailing 12 Months  
Capital Gain 1.70% 62% D 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.70% 62% D 31% F
Trailing 5 Years  
Capital Gain 56.16% 58% F 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 56.16% 58% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.98% 100% F 75% C
Dividend Return 14.98% 100% F 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.73% 38% F 36% F
Risk Adjusted Return 50.37% 85% B 65% D
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.